Loading...
Projects / Programmes
A double whammy for the NF-κB signalling pathway: development of TAK1 and IKKβ degraders against inflammation-driven diseases
Research activity
| Code | Science | Field | Subfield |
|---|---|---|---|
| 1.09.00 | Natural sciences and mathematics | Pharmacy |
| Code | Science | Field |
|---|---|---|
| 3.01 | Medical and Health Sciences | Basic medicine |
Evaluation
(metodology)
Points
4,367.84
A''
984.24
A'
2,620.01
A1/2
3,387.45
CI10
6,902
CImax
177
h10
43
A1
16.32
A3
0.29
Data for the last 5 years (citations for the last 10 years) on
May 9, 2026;
Data for score A3 calculation refer to period
2020-2024
Data for ARIS tenders (
04.04.2019 – Programme tender,
archive
)
Citations
Citations for bibliographic records in COBIB.SI that are linked to records in citation databases
| Database | Linked records | Citations | Pure citations | Average pure citations |
|---|---|---|---|---|
| WoS | 342 | 8,000 | 6,735 | 19.69 |
| Scopus | 346 | 8,668 | 7,301 | 21.1 |
Organisations (1) , Researchers (6)
0787 University of Ljubljana, Faculty of Pharmacy
| no. | Code | Name and surname | Research area | Role | Period | No. of publicationsNo. of publications |
|---|---|---|---|---|---|---|
| 1. | 53656 | Pharmacy | Researcher | 2024 - 2026 | 42 | |
| 2. | 32034 | Oncology | Researcher | 2024 - 2026 | 234 | |
| 3. | 36438 | Pharmacy | Researcher | 2024 - 2026 | 284 | |
| 4. | 30816 | Pharmacy | Head | 2024 - 2026 | 302 | |
| 5. | 52378 | Pharmacy | Researcher | 2024 - 2026 | 46 | |
| 6. | 28334 | Pharmacy | Researcher | 2024 - 2026 | 459 |